Schedule 13D ownership disclosure
Keenova Therapeutics PLC
Ordinary Shares, par value $0.01 per share · CUSIP: G5890A102
Event date: 2025-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- GoldenTree Asset Management LPReported CIK 0001278951
Shares: 7,926,176.00 · Class: 20.1%
- GoldenTree Asset Management LLCReported CIK 0001435627
Shares: 7,926,176.00 · Class: 20.1%
- Steven A. TananbaumReported CIK 0001435626
Shares: 7,946,176.00 · Class: 20.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-022600
- Form type
- SCHEDULE 13D
- Filer
- GOLDENTREE ASSET MANAGEMENT LP
- CIK
- CIK 1278951
- Filed
- Aug 07, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13D beneficial ownership